BALTIMORE, MD (April 19, 2013)– The American Urological Association (AUA), today announced that it will co-host two U.S. Food and Drug Administration (FDA) public workshops to address research in the areas of bladder and prostate cancer. The events, free and open to the public, will take place in San Diego on May 5 and May 6, during the AUA’s annual scientific meeting.
The first event, “Clinical Trial Design Issues: Drug and Device Development for Localized Prostate Cancer” will be held on May 5, from 8 a.m. to 5 p.m. and will feature key leaders in the field of prostate cancer, including physicians, advocates and industry representatives from a variety of specialties, including urology, radiation oncology, medical oncology, biostatistics and experts in clinical trial methodology. The second, “Clinical Trial Design Issues: Development of New Therapies for Non-Muscle Invasive Bladder Cancer” will take place on May 6 from 1 p.m. to 5 p.m. Both events will be held at the Manchester Grand Hyatt Hotel in San Diego.
These educational workshops are designed to provide beneficial and comprehensive information on clinical trials to both medical professionals and the general public. Panels will discuss trial designs and study endpoints for prostate and bladder cancer trials, as well as strategies to foster clinical cancer research.
“The overall objective of this workshop is to discuss and develop new pathways for drug approval in localized prostate and bladder cancer,” said Dr. Johannes Vieweg, chair of the AUA’s Research Council. Drug or device development is currently hampered by a lack of validated clinical trial endpoints and this workshop is designed to aid with accelerating the pipeline of new drugs and devices with benefit to our patients.
“We are honored and pleased that the FDA chose to work with the AUA on these initiatives.”
More information about the prostate cancer workshop can be found online by visiting the FDA website at http://www.fda.gov/Drugs/NewsEvents/ucm348372.htm. More about the bladder cancer event can be found online by visiting http://www.fda.gov/Drugs/NewsEvents/ucm348373.htm.
NOTE TO REPORTERS: Expert spokespeople are available to discuss this story. Please contact the Communications Office at 410-689-3932 for more information or to arrange an interview.
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 19,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
Wendy Waldsachs Isett, AUA